English   español  

Navegación por Autor Leblond, Véronique

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 3 a 6 de 6 < Anterior 
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
closedAccessaccesoRestringido.pdf.jpgnov-2018Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party StudyPaviglianiti, Annalisa; Tozatto Maio, Karina; Rocha, Vanderson; Gehlkopf, Eve; Milpied, Noel; Esquirol, Albert; Chevallier, Patrice; Blaise, Didier; Gac, Anne-Claire; Leblond, Véronique; Yves Cahn, Jean; Abecasis, Manuel; Zuckerman, Tsila; Schouten, Harry; Gurman, Gunhan; Rubio, Marie Thérèse; Beguin, Yves; López-Corral, L.; Nagler, Arnon; Snowden, John A.; Koc, Yener; Mordini, Nicola; Bonifazi, Francesca; Volt, Fernanda; Kenzey, Chantal; Robinson, Stephen Paul; Montoto, Silvia; Gluckman, Eliane; Ruggeri, Annalisaartículo
openAccess23-feb-2023Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemiaBuske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Véronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P.; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israelartículo
closedAccessaccesoRestringido.pdf.jpgmar-2023Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and managementTerpos, Evangelos; Branagan, A. R.; García-Sanz, Ramón; Trotman, Judith; Greenberger, L. M.; Stephens, D. M.; Morel, P.; Kimby, E.; Frustaci, A. M.; Hatjiharissi, E.; San-Miguel, Jesús; Dimopoulos, Meletios A.; Treon, Steven P.; Leblond, Véroniqueartículo
openAccessDS_JCO.21.00838.pdf.jpg2022Supplementary files of the article Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström’s Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study [Dataset]Buske, Christian; Tedeschi, Alessandra; Trotman, Judith; García-Sanz, Ramón; MacDonald, David; Leblond, Véronique; Mahe, Beatrice; Herbaux, Charles; Matous, Jeffrey V.; Tam, Constantine S.; Heffner, Leonard T.; Varettoni, Marzia; Palomba, M. Lia; Shustik, Chaim; Kastritis, Efstathios; Treon, Steven P.; Ping, Jerry; Hauns, Bernhard; Arango-Hisijara, Israel; Dimopoulos, Meletios A.dataset